About
Twenty years research experience in the area of drug design and discovery from herbal and synthetic sources. During this period actively worked on following important research projects:
I Development of traditional herbal drugs as Immunomodulators/Adaptogens.
II Development of anti-diabetic agents.
III Prospecting biodiversity for its chemistry and bioactivity.
IV Newer Scientific Herbal Preparation for Global Positioning.
V Herbal Based Preparations for Degenerative Disorders: Diabetes mellitus type II (NIDDM) with emphasis on insulin sensitization and Herboprint-A tool for standardization of herbal medicine.
VI Golden Triangle Partnership Programme.
VII Design, Synthesis of Novel Sugar-Oxasteroid-Quinones as Non-Steroidal Dissociated Glucocorticoid Receptor (GR) Agonists for Rheumatoid Arthritis.
VIII Studied the Anti-inflammatory molecules from Boswellia serrata for Rheumatoid Arthritis.
IX Development of boswellic acid analogue as Anti-arthritic agent through combinatorial approach.
Employment
-
Indian Institute of Integrative Medicine Senior Principal Scientist
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Evaluation of the immunomodulatory and anti-inflammatory activity of Bakuchiol using RAW 264.7 macrophage cell lines and in animal models stimulated by lipopolysaccharide (LPS). Save
- Acteoside ameliorates inflammatory responses through NFkB pathway in alcohol induced hepatic damage Save
- Murrayanine Attenuates Lipopolysaccharide‐induced Inflammation and Protects Mice from Sepsis‐associated Organ Failure Save
- Correction: Four new carbazole alkaloids from Murraya koenigii that display anti-inflammatory and anti-microbial activities. Save
- Kaempferol-3-o-β-d-glucuronate exhibit potential anti-inflammatory effect in LPS stimulated RAW 264.7 cells and mice model. Save
- The amino analogue of β-boswellic acid efficiently attenuates the release of pro-inflammatory mediators than its parent compound through the suppression of NF-κB/IκBα signalling axis. Save
- Biopharmaceutic parameters, pharmacokinetics, transport and CYP-mediated drug interactions of IIIM-017: A novel nitroimidazooxazole analogue with anti-tuberculosis activity. Save
- Anti-inflammatory potential of hentriacontane in LPS stimulated RAW 264.7 cells and mice model. Save
- Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis. Save
- Four new carbazole alkaloids from Murraya koenigii that display anti-inflammatory and anti-microbial activities. Save